Short-chain fatty acids abrogate Japanese encephalitis virus-induced inflammation in microglial cells via

Atreye Majumdar1, Indira Priya Siva Venkatesh1, Vivek Swarup2,3

  • 1National Brain Research Centre, Manesar, Haryana, India.

Mbio
|June 13, 2024
PubMed

Insights

Short-chain fatty acids (SCFAs) reduce inflammation in Japanese encephalitis virus-infected brain cells. These gut metabolites, via miR-200a-3p and ZBTB20, regulate the NF-κB pathway, offering potential strategies against viral neuroinflammation.

Area of Science:

  • Neuroscience
  • Microbiology
  • Immunology

Background:

  • Japanese encephalitis virus (JEV) causes viral encephalitis with potential for long-term neurological damage.
  • The gut-brain axis, mediated by gut microbiota metabolites like short-chain fatty acids (SCFAs), influences brain health.
  • SCFAs are known to modulate inflammatory responses.

Purpose of the Study:

  • To investigate the microRNA (miRNA)-based mechanisms by which SCFAs exert anti-inflammatory effects in an in vitro model of JEV infection.
  • To elucidate the role of SCFA-modulated miRNAs in regulating inflammatory pathways within microglial cells.

Main Methods:

  • N9 microglial cells were pre-treated with an SCFA cocktail followed by JEV infection.
  • Analysis included cytokine bead assays, immunoblotting, PCR, and miRNA sequencing (Illumina Hiseq).
  • Bioinformatic analyses (WGCNA) and functional experiments (miRNA mimic/inhibitor, luciferase assay) were employed to identify miRNA-target interactions.

Main Results:

  • SCFAs significantly reduced pro-inflammatory markers (MCP1, TNFα) and phospho-NF-κB activation in JEV-infected cells.
  • miRNA sequencing identified 160 differentially expressed miRNAs; miR-200a-3p was identified as a key upregulated miRNA.
  • miR-200a-3p was validated to target ZBTB20 and regulate Iκβα, thereby dampening the NF-κB signaling pathway.

Conclusions:

  • SCFAs attenuate JEV-induced neuroinflammation by modulating specific miRNA pathways.
  • The miR-200a-3p/ZBTB20 interaction plays a crucial role in regulating the NF-κB pathway in response to SCFAs.
  • These findings highlight potential therapeutic strategies targeting the gut-brain axis for managing viral neuroinflammation.